Changes in the use of psychotropic drugs during the course of Alzheimer's disease: A large‐scale longitudinal study of French medical records-Reference-Cited by-同舟云学术

Changes in the use of psychotropic drugs during the course of Alzheimer's disease: A large‐scale longitudinal study of French medical records

Published:2021-01 Issue:1 Volume:7 Page:
ISSN:2352-8737
Container-title:Alzheimer's & Dementia: Translational Research & Clinical Interventions
language:en
Short-container-title:A&D Transl Res & Clin Interv

Author:

Ansart Manon¹²^ORCID,Epelbaum Stéphane¹²³,Houot Marion¹⁴,Nedelec Thomas¹²,Lekens Béranger⁵,Gantzer Laurène⁵,Dormont Didier¹²⁶,Durrleman Stanley¹²

Affiliation:

1. Sorbonne Universités UPMC Univ Paris 06 Inserm CNRS Institut du cerveau et la moelle épinière (ICM) ‐ Hôpital de la Pitié‐Salpêtrière Paris France

2. Inria Paris Aramis project‐team Paris France

3. Department of Neurology AP‐HP Hôpital de la Pitié‐Salpêtrière Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A) Reference Center for Rare or Early Dementias and Center of Excellence of Neurodegenerative Disease (CoEN) Paris France

4. Sorbonne University Alzheimer Precision Medicine (APM) AP‐HP Hôpital de la Pitié‐Salpêtrière Paris France

5. CEGEDIM R&D Boulogne‐Billancourt Paris France

6. Department of Neuroradiology AP‐HP Hôpital de la Pitié‐Salpêtrière Paris France

Funder

H2020 European Research Council

Agence Nationale de la Recherche

Publisher

Wiley

Subject

Psychiatry and Mental health,Neurology (clinical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/trc2.12210

Reference54 articles.

1. The global prevalence of dementia: A systematic review and metaanalysis

2. The economic cost of dementia: A systematic review

3. 2020 Alzheimer's disease facts and figures

4. Implications of the Facing Dementia Survey for health care professionals across Europe

5. How many patients are eligible for disease-modifying treatment in Alzheimer’s disease? A French national observational study over 5 years